Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Sun, Zheng  [Clear All Filters]
Journal Article
Ma X, Chen L, Yang Y, Zhang W, Wang P, Zhang K, Zheng B, Zhu L, Sun Z, Zhang S, et al. An Artificial Intelligent Signal Amplification System for Detection of miRNA. Front Bioeng Biotechnol. 2019;7:330.
Wang L, Yin P, Wang J, Wang Y, Sun Z, Zhou Y, Guan X. Delivery of mesenchymal stem cells-derived extracellular vesicles with enriched miR-185 inhibits progression of OPMD. Artif Cells Nanomed Biotechnol. 2019;47(1):2481-2491.
Sun Z, Chen Z, Yin M, Wu X, Guo B, Cheng X, Quan R, Sun Y, Zhang Q, Fan Y, et al. Harnessing developmental dynamics of spinal cord extracellular matrix improves regenerative potential of spinal cord organoids. Cell Stem Cell. 2024.
Shlevkov E, Basu H, Bray M-A, Sun Z, Wei W, Apaydin K, Karhohs K, Chen P-F, Smith JLM, Wiskow O, et al. A High-Content Screen Identifies TPP1 and Aurora B as Regulators of Axonal Mitochondrial Transport. Cell Rep. 2019;28(12):3224-3237.e5.
Song J, He Q, Guo X, Wang L, Wang J, Cui C, Hu H, Yang M, Cui Y, Zang N, et al. Mesenchymal stem cell-conditioned medium alleviates high fat-induced hyperglucagonemia via miR-181a-5p and its target PTEN/AKT signaling. Mol Cell Endocrinol. 2021:111445.
He Q, Song J, Cui C, Wang J, Hu H, Guo X, Yang M, Wang L, Yan F, Liang K, et al. Retraction Note: Mesenchymal stem cell-derived exosomal miR-146a reverses diabetic β-cell dedifferentiation. Stem Cell Res Ther. 2022;13(1):497.